10/04/2024
4:09 PM | Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:06 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:22 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2024
3:27 PM | Blueprint Medicines (Subject)
Landsittel Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
4:06 PM | Blueprint Medicines (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
3:50 PM | Blueprint Medicines (Subject)
Lee Philina (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
3:48 PM | Blueprint Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
08/01/2024
6:29 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
6:07 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
6:08 PM | Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:54 PM | Blueprint Medicines (Subject)
Durso-Bumpus Debra (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2024
3:36 PM | Blueprint Medicines (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/14/2024
4:32 PM | Blueprint Medicines (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:32 PM | Blueprint Medicines (Issuer)
Borisy Alexis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:34 PM | Blueprint Medicines (Issuer)
Goldberg Mark Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:34 PM | Blueprint Medicines (Issuer)
Lydon Nicholas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:35 PM | Blueprint Medicines (Issuer)
Seely Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:36 PM | Blueprint Medicines (Issuer)
Tsai John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:37 PM | Blueprint Medicines (Issuer)
COATS LONNEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:38 PM | Beckman Daniella (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:41 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:11 PM | Blueprint Medicines (Subject)
Carter Percy H. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/04/2024
3:40 PM | Blueprint Medicines (Subject)
Hewes L. Becker (Reporting)
Hewes L. Becker (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
3:38 PM | Blueprint Medicines (Subject)
Hewes L. Becker (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024
7:00 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
4:19 PM | Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
4:26 PM | Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
3:43 PM | Blueprint Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024
6:09 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
6:09 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
4:24 PM | Blueprint Medicines (Filer)
| Form DEF 14A | |
04/25/2024
4:25 PM | Blueprint Medicines (Filer)
| Form ARS | |
04/25/2024
7:30 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
11:58 AM | Blueprint Medicines (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
| Form SC 13G/A | |
03/28/2024
4:57 PM | Blueprint Medicines (Subject)
Landsittel Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2024
8:11 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:50 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:22 PM | Blueprint Medicines (Subject)
Landsittel Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
3:46 PM | Blueprint Medicines (Subject)
Hurley Ariel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
3:47 PM | Blueprint Medicines (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:17 PM | Blueprint Medicines (Subject)
Lee Philina (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
$5k to $1.3m in just 3 trades (Ad) It doesn’t happen often, but occasionally, something completely unique comes across my radar.
In this case, I’m talking about legal “Insider Trading”.
Traders who have consistently signaled 453% … 610% .. and even 1036%... gains.
And until now they have been doing it completely under the radar.
In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade. Register for the imminent briefing here. |
03/11/2024
5:24 PM | Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:26 PM | Blueprint Medicines (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:27 PM | Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:28 PM | Blueprint Medicines (Issuer)
Durso-Bumpus Debra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:29 PM | Blueprint Medicines (Issuer)
Hewes L. Becker (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:15 PM | Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:18 PM | Blueprint Medicines (Issuer)
McCain Tracey L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:19 PM | Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:20 PM | Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:21 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:23 PM | Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:22 PM | Blueprint Medicines (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:15 PM | Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:16 PM | Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:17 PM | Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:18 PM | Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:19 PM | Blueprint Medicines (Issuer)
Hewes L. Becker (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:20 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:20 PM | Blueprint Medicines (Issuer)
Durso-Bumpus Debra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:21 PM | Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
9:41 AM | Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:19 PM | Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
2:06 PM | Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:03 PM | Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024
7:20 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
3:40 PM | Blueprint Medicines (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/15/2024
4:26 PM | Blueprint Medicines (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
6:05 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
5:54 PM | Blueprint Medicines (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
7:35 AM | Blueprint Medicines (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/29/2024
5:13 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
8:46 AM | BlackRock Inc. (Filed by)
Blueprint Medicines (Subject)
| Form SC 13G/A | |
01/10/2024
9:16 AM | Blueprint Medicines (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
01/08/2024
7:03 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2023
3:24 PM | Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
2:56 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
5:09 PM | Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
7:45 PM | Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/24/2023
12:17 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023
8:02 AM | Blueprint Medicines (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
10/30/2023
1:01 PM | Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2023
6:00 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
